Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes (Q4666685): Difference between revisions

From MaRDI portal
Import240304020342 (talk | contribs)
Set profile property.
ReferenceBot (talk | contribs)
Changed an Item
 
Property / cites work
 
Property / cites work: One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Bivariate Sequential Designs for Phase II Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Designs for Phase II Trials Allowing for a Trade-Off between Response and Toxicity / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Sample-Size-Optimal Bayesian Procedure for Sequential Pharmaceutical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Why Isn't Everyone a Bayesian? / rank
 
Normal rank
Property / cites work
 
Property / cites work: One-Sample Multiple Testing Procedure for Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic Designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3484242 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sample Size Determination for Phase II Clinical Trials Based on Bayesian Decision Theory / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Bayesian Approach to the Design of Phase II Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Practical Bayesian Guidelines for Phase IIB Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q5783814 / rank
 
Normal rank

Latest revision as of 20:34, 7 June 2024

scientific article; zbMATH DE number 2155956
Language Label Description Also known as
English
Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
scientific article; zbMATH DE number 2155956

    Statements

    Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    13 April 2005
    0 references
    0 references
    0 references
    0 references
    0 references
    backward induction
    0 references
    clinical trial design
    0 references
    optimal stopping
    0 references
    safety and efficacy minotoring
    0 references
    sequential procedure
    0 references
    0 references